NOS2 and gastroesophageal reflux disease: iNOS-produced NO induces LES relaxation leading to the development of GERD, and in a mouse model of sepsis infected with lipopolysaccharides, the LES releases INOS causing impaired LES contraction, which can be blocked by utilizing NOS inhibitors (58).